Eu­ro­pean reg­u­la­tor rec­om­mends ap­proval of Carvyk­ti in ear­li­er lines of mul­ti­ple myelo­ma

A Eu­ro­pean Med­i­cines Agency com­mit­tee rec­om­mend­ed that the la­bel for Leg­end Biotech and John­son & John­son’s CAR-T Carvyk­ti be ex­pand­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA